The AlzForum’s editorial team provides a comprehensive recap of the last year in Alzheimer’s research and related public policy developments. Post navigationPreviousPrevious post:FDA’s Early AD Draft Guidance for Industry on Drug Development for Treatments in Early Alzheimer’s DiseaseNextNext post:American Academy of Neurology Updates Practice Guideline for Mild Cognitive Impairment (MCI)